Text Messaging Intervention to Improve ART Adherence among HIV-positive Youth
Text Messaging Intervention to Improve ART Adherence among HIV-positive Youth
批准号:
8311781
负责人:
Robert Garofalo
金额:
$20.94万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-30 至 2014-05-31
关键词:
AdherenceAgeAlcohol or Other Drugs useAlcoholsBiological MarkersCD4 Lymphocyte CountCellular PhoneClinicClinical TrialsControl GroupsDataEffectivenessEnrollmentFeasibility StudiesGenetic Crossing OverHIVHIV SeropositivityInfectionInterventionIntervention TrialLifeMeasuresMinorityOutcomeParticipantPatientsPharmaceutical PreparationsPopulation DecreasesPopulation StudyRandomizedRandomized Clinical TrialsRandomized Controlled TrialsReportingSample SizeSamplingScheduleServicesSiteTechnologyTestingTextTransfusionViral Load resultVisualYouthadolescent substance useanalogburden of illnesscontrol trialeffective interventionfollow-upgroup interventionhigh riskimprovedintervention effectmedication compliancepost interventionpractical applicationprimary outcomeresponsesatisfactionsecondary outcomestandard of careyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
As emphasized in PAS-10-098, youth living with HIV (YLH) are a vulnerable subpopulation. The majority of
YLH are of minority status, are likely to use illicit substances, and often struggle with adherence to HIV
medications. The purpose of the proposed study is to test SMS text messaging technology to improve
medication adherence among YLH. The proposed study is a randomized controlled trial of the effect of text
message reminders on ART adherence among non-adherent YLH, ages 16-29. Daily text message reminders
will be sent to patients randomized to the intervention group according to their medication schedule, for 6
months. A small feasibility study (N=25), including a high percentage of youth in need of alcohol and/or drug
treatment (i.e., 60%), provided preliminary evidence of the potential effectiveness of this approach. We will
enroll 152 non-adherent YLH, ages 16-29. Half of the sample (N=76), randomized to the intervention, will
receive daily SMS text message medication reminders and half will be randomized to the control condition
(N=76) and receive standard of care (SOC) only. For the controlled trial, adherence levels and viral load will be
collected at baseline, 3-month and 6-month follow-up. In addition, at the end of the initial 6-month enrollment
period, participants in the control condition will cross-over to the SMS intervention and participants in the
intervention condition will cease to receive the SMS intervention. Adherence and viral load data will be
collected from each group at 9- and 12-month follow-up points. The advantages of these additional features
are that they allow us to offer the intervention to all participants, to evaluate the intervention effect in the control
group (to confirm the intervention effect) and to assess sustained intervention effects in the intervention group
(post-intervention). We hypothesize that youth in the intervention condition will demonstrate a clinically
meaningful increase in adherence at 3 and 6 months post-baseline, from approximately 70% to 90%
adherence to ART. Our specific aims are: 1) to determine the efficacy of an SMS text messaging intervention
on our primary outcome: adherence to ART among poorly adherent YLH, ages 16-29 (a group shown to be at
high risk for substance use) over a 6-month intervention period; 2) to explore the efficacy of an SMS text
messaging intervention on a secondary, exploratory outcome: viral load and CD4 counts, over a 6-month
intervention period; 3) to assess the feasibility, acceptability, and satisfaction of this intervention and clinical
trial approach by both objective and subjective measures. Our primary hypotheses are: 1) youth randomized to
the SMS text messaging intervention will show greater improvements in levels of adherence to ART and
secondary outcomes during the intervention period at 3 and 6 months post-baseline, in comparison to those
receiving SOC only. We hypothesize a 10-point difference in adherence level between groups at 3 and 6
months for the intervention to be clinically meaningful; 2) youth randomized to SMS text messaging
intervention will maintain improvements (i.e., > 90% adherence) at 9-month and 12-month follow-ups.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1007/s10461-015-1192-x
发表时间:
2016-05
期刊:
AIDS and behavior
影响因子:
4.4
作者:
[Garofalo R, Kuhns LM, Hotton A, Johnson A, Muldoon A, Rice D]
通讯作者:
Rice D
Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness / Implementation Hybrid Study
-
批准号:10749347
-
项目类别:
-
资助金额:$141.02万
-
财政年份:2023
-
负责人:Robert Garofalo
-
依托单位:
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
-
批准号:10818851
-
项目类别:
-
资助金额:$116.46万
-
财政年份:2023
-
负责人:Robert Garofalo
-
依托单位:
Development and Testing of MyPEEPS Mobile for Young Transgender Men
-
批准号:10544319
-
项目类别:
-
资助金额:$31.92万
-
财政年份:2022
-
负责人:Robert Garofalo
-
依托单位:
Development and Testing of MyPEEPS Mobile for Young Transgender Men
-
批准号:10407736
-
项目类别:
-
资助金额:$34.15万
-
财政年份:2022
-
负责人:Robert Garofalo
-
依托单位:
Intensive Combination Approach to Rollback the Epidemic (iCARE) in Nigerian Adolescents
-
批准号:10046115
-
项目类别:
-
资助金额:$37.64万
-
财政年份:2020
-
负责人:Robert Garofalo
-
依托单位:
mLab App for Improving Uptake of rapid HIV self-testing and Linking Youth to Care
-
批准号:9927670
-
项目类别:
-
资助金额:$81.64万
-
财政年份:2018
-
负责人:Robert Garofalo
-
依托单位:
mLab App for Improving Uptake of rapid HIV self-testing and Linking Youth to Care
-
批准号:10404092
-
项目类别:
-
资助金额:$77.24万
-
财政年份:2018
-
负责人:Robert Garofalo
-
依托单位:
mLab App for Improving Uptake of rapid HIV self-testing and Linking Youth to Care
-
批准号:10160957
-
项目类别:
-
资助金额:$81.58万
-
财政年份:2018
-
负责人:Robert Garofalo
-
依托单位:
mLab App for Improving Uptake of rapid HIV self-testing and Linking Youth to Care
-
批准号:9755512
-
项目类别:
-
资助金额:$82.92万
-
财政年份:2018
-
负责人:Robert Garofalo
-
依托单位:
Adaptive intervention strategies trial for strengthening adherence to antiretroviral HIV treatment among youth
-
批准号:10371803
-
项目类别:
-
资助金额:$59.15万
-
财政年份:2016
-
负责人:Robert Garofalo
-
依托单位:
A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV prevention Behaviors in Diverse Adolescent MSM
-
批准号:9902191
-
项目类别:
-
资助金额:$157.58万
-
财政年份:2016
-
负责人:Robert Garofalo
-
依托单位:
Adaptive intervention strategies trial for strengthening adherence to antiretroviral HIV treatment among youth
-
批准号:9357686
-
项目类别:
-
资助金额:$62.78万
-
财政年份:2016
-
负责人:Robert Garofalo
-
依托单位:
A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV prevention Behaviors in Diverse Adolescent MSM
-
批准号:9569861
-
项目类别:
-
资助金额:$7.96万
-
财政年份:2016
-
负责人:Robert Garofalo
-
依托单位:
Employing eSBI in a Community-based HIV Testing Environment for At-risk Youth
-
批准号:9054477
-
项目类别:
-
资助金额:$64.08万
-
财政年份:2015
-
负责人:Robert Garofalo
-
依托单位:
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
-
批准号:8556766
-
项目类别:
-
资助金额:$69.15万
-
财政年份:2013
-
负责人:Robert Garofalo
-
依托单位:
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
-
批准号:9247834
-
项目类别:
-
资助金额:$47.74万
-
财政年份:2013
-
负责人:Robert Garofalo
-
依托单位:
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
-
批准号:8650296
-
项目类别:
-
资助金额:$59.38万
-
财政年份:2013
-
负责人:Robert Garofalo
-
依托单位:
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
-
批准号:8826797
-
项目类别:
-
资助金额:$60.29万
-
财政年份:2013
-
负责人:Robert Garofalo
-
依托单位:
HIV Prevention Intervention for Young Transgender Women
-
批准号:8215419
-
项目类别:
-
资助金额:$74.22万
-
财政年份:2011
-
负责人:Robert Garofalo
-
依托单位:
HIV Prevention Intervention for Young Transgender Women
-
批准号:8457098
-
项目类别:
-
资助金额:$74.92万
-
财政年份:2011
-
负责人:Robert Garofalo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: